| Literature DB >> 35111366 |
Katarzyna Domaszewska1, Michał Boraczyński2, Yi-Yuan Tang3, Joanna Gronek4, Krystian Wochna5, Tomasz Boraczyński6, Dariusz Wieliński7, Piotr Gronek4.
Abstract
Aging is a complex, multietiological process and a major risk factor for most non-genetic, chronic diseases including geriatric syndromes that negatively affect healthspan and longevity. In the scenario of "healthy or good aging", especially during the COVID-19 era, the proper implementation of exercise as "adjuvant" or "polypill" to improve disease-related symptoms and comorbidities in the general population is a top priority. However, there is still a gap concerning studies analyzing influence of exercise training to immune system in older people. Therefore, the aim of this review is to provide a brief summary of well-established findings in exercise immunology and immunogerontology, but with a focus on the main exercise-induced mechanisms associated with aging of the immune system (immunosenescence). The scientific data strongly supports the notion that regular exercise as a low-cost and non-pharmacological treatment approach, when adjusted on an individual basis in elderly, induce multiple rejuvenating mechanisms: (1) affects the telomere-length dynamics (a "telo-protective" effect), (2) promote short- and long-term anti-inflammatory effects (via e.g., triggering the anti-inflammatory phenotype), 3) stimulates the adaptive immune system (e.g., helps to offset diminished adaptive responses) and in parallel inhibits the accelerated immunosenescence process, (4) increases post-vaccination immune responses, and (5) possibly extends both healthspan and lifespan. Copyright:Entities:
Keywords: COVID-19; aging process; exercise; immune system; immunosenescence
Year: 2022 PMID: 35111366 PMCID: PMC8782560 DOI: 10.14336/AD.2021.1219
Source DB: PubMed Journal: Aging Dis ISSN: 2152-5250 Impact factor: 6.745
Figure 1.Mechanism of exercise in activation of anti-inflammatory phenotype in different tissues. PGC1α: peroxisome proliferator-activated receptor γ co-activator 1α, IL-6: interleukin 6, NFAT: nuclear factor of activated T-cells, MAPK: mitogen-activated protein kinase, sTNFr: soluble tumour necrosis factor receptors, IL-1RA: interleukin 1 receptor antagonist, TNF-α: tumour necrosis factor alpha, IL-1: interleukin 1, CRP: C-reactive protein. Figure adapted from Metsios et al. [20]